Jung Melita Sun 4
4 · Terns Pharmaceuticals, Inc. · Filed May 2, 2024
Insider Transaction Report
Form 4
Jung Melita Sun
Chief Business Officer
Transactions
- Award
Stock Option (Right to buy)
2024-05-01+475,000→ 475,000 totalExercise: $5.08Exp: 2034-04-30→ Common Stock (475,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from May 1, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.